level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 80 /hr
Hire Dr. Nathalie P.
United States
USD 80 /hr

Neuroscientist | CNS & Rare diseases | Pharmacology | Preclinical & Clinical development | Translational science

Profile Summary
Subject Matter Expertise
Services
Writing Non-Medical Regulatory Writing, Technical Writing
Research Feasibility Study, Technology Scouting
Work Experience

Founder/ Principal consultant

Neuro-Xplore

July 2024 - Present

Associate Director Neuroscience

Brii Biosciences

2022 - 2024

Senior Scientist

Neurona Therapeutics

2021 - 2022

Research scientist/ Associate in Neurology

Boston Children's Hospital

2018 - 2021

Research fellow

Harvard Medical School

October 2009 - 2017

Instructor Neurobiology-Physiology

Université Toulouse III - Paul Sabatier

2008 - 2009

Education

PhD

Université de Picardie Jules Verne

- Present

Master Neuropharmacology

Université de Bordeaux

- Present

BS Biochemistry

Université Paris Diderot - Paris 7

- Present

Certifications
  • Introduction to the Principles and Practice of Clinical Research Introduction to the Principles and Practice of Clinical Research

    NIH - Office of Clinical Research Education & Collaboration Outreach

    May 2024 - June 2024

  • Principles of Clinical Pharmacology 2023-2024

    NIH - Office of Clinical Research Education & Collaboration Outreach

    April 2024 - May 2024

Publications
JOURNAL ARTICLE
Mansi Parekh, Philip Hampel, Marina Radoul, Eric Steven Sevilla, David Traver, Hannah Kim, Nathalie Picard, Andrew Adler, Luis Fuentealba, Jiayin Li, et al. (2022). Preclinical Development of NRTX-1001, an Inhibitory Interneuron Cellular Therapeutic for the Treatment of Chronic Focal Epilepsy (S13.007) . Neurology.
Picard N, Fagiolini M(2019). MeCP2: an epigenetic regulator of critical periods . Current opinion in neurobiology.
Picard N, Takesian AE, Fagiolini M, Hensch TK(2019). NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity . Molecular psychiatry.
Thompson AD, Picard N, Min L, Fagiolini M, Chen C(2016). Cortical Feedback Regulates Feedforward Retinogeniculate Refinement . Neuron.
Patrizi A, Picard N, Simon AJ, Gunner G, Centofante E, Andrews NA, Fagiolini M(2015). Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype . Biological psychiatry.
Picard N, Leslie JH, Trowbridge SK, Subramanian J, Nedivi E, Fagiolini M(2014). Aberrant development and plasticity of excitatory visual cortical networks in the absence of cpg15 . The Journal of neuroscience : the official journal of the Society for Neuroscience.
Picard N, Guénin S, Perrin Y, Hilaire G, Larnicol N(2008). Prenatal diazepam exposure alters respiratory control system and GABAA and adenosine receptor gene expression in newborn rats . Pediatric research.